Showing results (261-270 of 372) with videos related to

Sort By:
Pageof 38
Neuro-Oncology Advances|December 11, 2020
Improved risk stratification in younger IDH wild-type glioblastoma patients by combining a 4-miRNA signature with MGMT promoter methylation statusKristian Unger, Daniel F Fleischmann, Viktoria Ruf, et al.
Neuro-Oncology|July 8, 2022
Quantitative proteomic landscapes of primary and recurrent glioblastoma reveal a protumorigeneic role for FBXO2-dependent glioma-microenvironment interactionsMarcel Buehler, Xiao Yi, Weigang Ge, et al.
Archives of Pathology & Laboratory Medicine|June 21, 2019
Data Sets for the Reporting of Tumors of the Central Nervous System: Recommendations From The International Collaboration on Cancer ReportingDavid N Louis, Pieter Wesseling, Sebastian Brandner, et al.
Neuro-Oncology|July 17, 2014
Assessing CpG island methylator phenotype, 1p/19q codeletion, and MGMT promoter methylation from epigenome-wide data in the biomarker cohort of the NOA-04 trialBenedikt Wiestler, David Capper, Volker Hovestadt, et al.
Neurology|September 27, 2013
Prognostic or predictive value of MGMT promoter methylation in gliomas depends on IDH1 mutationWolfgang Wick, Christoph Meisner, Bettina Hentschel, et al.
Brain Pathology (Zurich, Switzerland)|August 31, 2025
cIMPACT-NOW update 11: Proposal on adaptation of diagnostic criteria for IDH- and H3-wildtype diffuse high-grade gliomas and for posterior fossa ependymal tumorsPieter Wesseling, David Capper, Guido Reifenberger, et al.
Neurological Research and Practice|May 22, 2022
AMPLIFY-NEOVAC: a randomized, 3-arm multicenter phase I trial to assess safety, tolerability and immunogenicity of IDH1-vac combined with an immune checkpoint inhibitor targeting programmed death-ligand 1 in isocitrate dehydrogenase 1 mutant gliomasLukas Bunse, Anne-Kathleen Rupp, Isabel Poschke, et al.
Cell Death & Disease|March 21, 2026
Berzosertib enhances the sensitivity of pediatric diffuse midline glioma H3K27-altered cells to radiotherapyNikita Gorainow, Felix Sander, Daniel Picard, et al.
Neuro-Oncology|February 6, 2018
SYK inhibition blocks proliferation and migration of glioma cells and modifies the tumor microenvironmentGerald Moncayo, Michal Grzmil, Tatiana Smirnova, et al.
Redox Biology|December 24, 2021
Glutaredoxin 2 promotes SP-1-dependent CSPG4 transcription and migration of wound healing NG2 glia and glioma cells: Enzymatic TaoismChristina Wilms, Klaudia Lepka, Felix Häberlein, et al.
Pageof 38